Tolerance to antidepressant treatment may be overcome by ketoconazole. Report of two cases [1]

Journal of Psychiatric Research

Volumn 37, Issue 2, 2003, Pages 171-173

  Sonino, Nicoletta ^a   Fava, Giovanni A ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DESIPRAMINE; FLUOXETINE; KETOCONAZOLE;

ADULT; CASE REPORT; CLINICAL FEATURE; CORTICOTROPIN BLOOD LEVEL; CUSHING DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG TOLERANCE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFORMED CONSENT; LETTER; MAJOR DEPRESSION; MALE; MELANCHOLIA; PRIORITY JOURNAL; RELAPSE; SCORING SYSTEM; STEROIDOGENESIS; TREATMENT OUTCOME;

EID: 0037772414     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(02)00089-4     Document Type: Letter

References (18)

1. Diagnostic and statistical manual of mental disorders (DSM-IV). 1994;APA, Washington, DC.
2. Baldessarini R.J., Ghaemi S.N., Viguera A.C. Tolerance in antidepressant treatment. Psychotherapy and Psychosomatics. 71:2002;177-179.
3. Byrne S.E., Rotschild A.J. Loss of antidepressant efficacy during maintenance therapy. Journal of Clinical Psychiatry. 59:1998;279-288.
4. Fava GA. Can long-term treatment with antidepressant drugs worsen the course of depression? Journal of Clinical Psychiatry (in press).
5. Fava GA, Ruini C, Rafanelli C, Grandi S. Cognitive behavioral approach to loss of clinical effect during long-term antidepressant treatment. American Journal of Psychiatry 2002;2094-2095.
6. Fava M., Schmidt M.E., Zhang S., Gonzales J., Raute N.J., Judge R. Treatment approaches to major depressive relapse: II. Reinitiation of antidepressant treatment. Psychotherapy and Psychosomatics. 71:2002;195-199.
7. Holsboer F. Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity. European Archives of Psychiatry and Neurological Sciences. 238:1989;302-322.
8. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression. implications for therapy Journal of Affective Disorders. 62:2001;77-91.
9. Malison R.T., Anand A., Pelton G.H., Kirwin P., Carpenter L., McDougle C.J., Heninger G.R., Price L.H. Limited efficacy of ketoconazole in treatment-refractory major depression. Journal of Clinical Psychopharmacology. 19:1999;466-470.
10. Paykel E.S. The Clinical Interview for Depression. Journal of Affective Disorders. 9:1985;85-96.
11. Ribeiro S.C., Tandon R., Grunhaus L., Greden J.F. The DST as a predictor of outcome in depression. American Journal of Psychiatry. 150:1993;1618-1629.
12. Sonino N. The use of ketoconazole as an inhibitor of steroid production. New England Journal of Medicine. 317:1987;812-818.
13. Sonino N., Boscaro M., Paoletta A., Mantero F., Ziliotto D. Ketoconazole treatment in Cushing's syndrome. Clinical Endocrinology. 35:1991;347-352.
14. Sonino N., Boscaro M. Medical therapy for Cushing's disease. Endocrinology and Metabolism Clinics of North America. 28:1999;211-222.
15. Sonino N., Fava G.A., Fallo F., Franceschetto A., Belluardo P., Boscaro M. Effect of serotonin antagonists ritanserin and ketanserin in Cushing's disease. Pituitary. 3:2000;55-59.
16. Sonino N., Fava G.A. CNS drugs in Cushing's disease. Pathophysiological and therapeutic implications for mood disorders. Progress in Neuropsychopharmacology and Biological Psychiatry. 26:2002;1011-1018.
17. Wolkowitz O.M., Reus V.I. Treatment of depression with antiglucocorticoid drugs. Psychosomatic Medicine. 61:1999;698-711.
18. Wolkowitz O.M., Reus V.I., Chan T., Manfredi P., Raum W., Johnson R., Garrick J. Antiglucocorticoid treatment of depression. Biological Psychiatry. 45:1999;1070-1074.